Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia - PubMed (original) (raw)
Review
. 1992 Oct:41 Suppl 2:36-41.
doi: 10.2337/diab.41.2.s36.
Affiliations
- PMID: 1526333
- DOI: 10.2337/diab.41.2.s36
Review
Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia
V M Monnier et al. Diabetes. 1992 Oct.
Abstract
Recent progress in structure elucidation of products of the advanced Maillard reaction now allows probing specifically for the role of this reaction in the pathogenesis of age- and diabetes-related complications. Pyrraline is a glucose-derived advanced glycation end product against which polyclonal and monoclonal antibodies have been raised. Immunohistochemical localization studies revealed that pyrraline is found predominantly in the sclerosed extracellular matrix of glomerular and arteriolar renal tissues from both diabetic and aged nondiabetic individuals. Pentosidine and carboxymethyllysine are Maillard end products derived from both glucose and ascorbate. In addition, pentosidine can be formed from several other sugars under oxidative conditions, and in vitro studies suggest that a common intermediate involving a pentose is a necessary precursor molecule. The highest levels of these advanced Maillard products are generally found in the extracellular matrix, but these products are also present in lens proteins and in proteins with a fast turnover such as plasma proteins. Diabetes, and especially uremia, greatly catalyzes pentosidine formation. Both conditions are characterized by accelerated cataractogenesis, atherosclerosis, and neuropathy, suggesting that molecular damage by advanced Maillard reaction products may be a common mechanism in their development.
Similar articles
- Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C. Miyata T, et al. J Am Soc Nephrol. 1998 Dec;9(12):2349-56. doi: 10.1681/ASN.V9122349. J Am Soc Nephrol. 1998. PMID: 9848790 - Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia.
Sell DR, Nagaraj RH, Grandhee SK, Odetti P, Lapolla A, Fogarty J, Monnier VM. Sell DR, et al. Diabetes Metab Rev. 1991 Dec;7(4):239-51. doi: 10.1002/dmr.5610070404. Diabetes Metab Rev. 1991. PMID: 1813279 Review. - New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed MU, Reddy S, Zyzak DV, Thorpe SR, Baynes JW. Wells-Knecht KJ, et al. Nephrol Dial Transplant. 1996;11 Suppl 5:41-7. doi: 10.1093/ndt/11.supp5.41. Nephrol Dial Transplant. 1996. PMID: 9044306 Review. - Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine.
Miyata T, Ueda Y, Shinzato T, Iida Y, Tanaka S, Kurokawa K, van Ypersele de Strihou C, Maeda K. Miyata T, et al. J Am Soc Nephrol. 1996 Aug;7(8):1198-206. doi: 10.1681/ASN.V781198. J Am Soc Nephrol. 1996. PMID: 8866413 - Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.
Odetti P, Fogarty J, Sell DR, Monnier VM. Odetti P, et al. Diabetes. 1992 Feb;41(2):153-9. doi: 10.2337/diab.41.2.153. Diabetes. 1992. PMID: 1733803
Cited by
- Investigating biochemical and structural changes of glycated collagen using multimodal multiphoton imaging, Raman spectroscopy, and atomic force microscopy.
Quansah E, Shaik TA, Çevik E, Wang X, Höppener C, Meyer-Zedler T, Deckert V, Schmitt M, Popp J, Krafft C. Quansah E, et al. Anal Bioanal Chem. 2023 Oct;415(25):6257-6267. doi: 10.1007/s00216-023-04902-5. Epub 2023 Aug 29. Anal Bioanal Chem. 2023. PMID: 37640827 Free PMC article. - Association of Inflammatory and Oxidative Status Markers with Metabolic Syndrome and Its Components in 40-to-45-Year-Old Females: A Cross-Sectional Study.
Šebeková K, Staruchová M, Mišľanová C, Líšková A, Horváthová M, Tulinská J, Lehotská Mikušová M, Szabová M, Gurecká R, Koborová I, Csongová M, Tábi T, Szökö É, Volkovová K. Šebeková K, et al. Antioxidants (Basel). 2023 Jun 5;12(6):1221. doi: 10.3390/antiox12061221. Antioxidants (Basel). 2023. PMID: 37371951 Free PMC article. - Vein morphometry in end-stage kidney disease: Teasing out the contribution of age, comorbidities, and vintage to chronic wall remodeling.
Labissiere X, Zigmond ZM, Challa A, Montoya C, Manzur-Pineda K, Abraham A, Tabbara M, Salama A, Pan Y, Salman LH, Yang X, Vazquez-Padron RI, Martinez L. Labissiere X, et al. Front Cardiovasc Med. 2022 Nov 7;9:1005030. doi: 10.3389/fcvm.2022.1005030. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36419492 Free PMC article. - Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility.
Willett TL, Voziyan P, Nyman JS. Willett TL, et al. Bone. 2022 Oct;163:116485. doi: 10.1016/j.bone.2022.116485. Epub 2022 Jul 4. Bone. 2022. PMID: 35798196 Free PMC article. Review. - Potential Mechanisms of the Improvement of Glucose Homeostasis in Type 2 Diabetes by Pomegranate Juice.
Olvera-Sandoval C, Fabela-Illescas HE, Fernández-Martínez E, Ortiz-Rodríguez MA, Cariño-Cortés R, Ariza-Ortega JA, Hernández-González JC, Olivo D, Valadez-Vega C, Belefant-Miller H, Betanzos-Cabrera G. Olvera-Sandoval C, et al. Antioxidants (Basel). 2022 Mar 15;11(3):553. doi: 10.3390/antiox11030553. Antioxidants (Basel). 2022. PMID: 35326203 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical